Testimonies from the Trenches Series - Reconsidering the Role of Urine Drug Testing in OUD Treatment (On-Demand)-Testimonies from the Trenches Series - Reconsidering the Role of Urine Drug Testing in OUD Treatment

Testimonies from the Trenches Series - Reconsidering the Role of Urine Drug Testing in OUD Treatment

Video Transcription

Video Summary

In this webinar, titled "Testimony from the Trenches: Innovations in Clinical Practice," Dr. John Lepley introduces the series and the speaker, Dr. Utsa Khatri. The webinar focuses on buprenorphine treatment for opioid use disorder and aims to challenge the status quo of how buprenorphine treatment has been provided in the past 20 years. Dr. Khatri, an assistant professor of emergency medicine at the Icahn School of Medicine at Mount Sinai, discusses the topic of urine drug testing in opioid use disorder treatment. She highlights the potential harms and benefits of urine drug testing, including its impact on the clinician-patient relationship and the potential trauma it can cause for patients with histories of violence and criminal justice involvement. Dr. Khatri also reviews the limited literature on the topic and the guidelines provided by the American Society of Addiction Medicine (ASAM) on the appropriate use of urine drug testing in addiction treatment. She concludes by raising discussion questions about the role of urine drug testing and its impact on patient outcomes and relationships.

Keywords

webinar

buprenorphine treatment

urine drug testing

clinician-patient relationship

patient outcomes

ASAM guidelines